Abeome Overview

  • Founded
  • 2000
  • Status
  • Private
  • Employees
  • 9
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 2

Abeome General Information


Developer of biotechnology products designed to help in the selection, analysis, and synthesis of monoclonal antibodies. The company's products offer the direct selection of desirable functional antibodies straight from the immune system of an immunized mouse, enabling medical practitioners with a monoclonal antibody to cure disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 150 Ben Burton Road
  • Bogart, GA 30622
  • United States
+1 (706) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Abeome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Secondary Transaction - Private 01-May-2021 00.00 Completed Generating Revenue
13. Grant 20-Sep-2016 00.000 00.00 Completed Generating Revenue
12. Later Stage VC 05-Jan-2016 000 00.00 Completed Generating Revenue
11. Grant 10-Feb-2014 00000 00.00 Completed Generating Revenue
10. Grant 15-Mar-2013 00000 00.00 Completed Generating Revenue
9. Grant 01-Nov-2010 00000 00.00 Completed Generating Revenue
8. Grant 01-Jan-2010 00000 00.00 Completed Generating Revenue
7. Later Stage VC 20-Jul-2008 00.00 Completed Generating Revenue
6. Seed Round 09-Jul-2007 $350K $2.1M Completed Generating Revenue
5. Grant 01-Jan-2007 $200K $1.75M Completed Generating Revenue
To view Abeome’s complete valuation and funding history, request access »

Abeome Executive Team (6)

Name Title Board Seat Contact Info
Trevor Thompson Executive
Kirby Alton Ph.D Executive Chairman
You’re viewing 2 of 6 executive team members. Get the full list »

Abeome Board Members (8)

Name Representing Role Since
Christopher McLeod Self Board Member 000 0000
Diana Murphy Abeome Board Member 000 0000
James Pitts III Self Board Member 000 0000
Kirby Alton Ph.D Abeome Executive Chairman 000 0000
Lewis Scruggs Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Abeome Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abeome Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Heart, Lung and Blood Institute Government 000 0000 000000 0
Small Business Innovative Research Grant Government 000 0000 000000 0
To view Abeome’s complete investors history, request access »